Get started
Author

Sachin Puri

Signaling Through OX40 Enhances Antitumor Immunity
2010 · Shawn M. Jensen, Levi D. Maston, et al. · Seminars in Oncology · 146
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
2015 · Zipei Feng, Sachin Puri, et al. · Journal for ImmunoTherapy of Cancer · 128
PDF
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights
2020 · Sachin Puri, Kapil Juvale · European Journal of Medicinal Chemistry · 104
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer
2019 · Akiko Suzuki, Sachin Puri, et al. · PLoS ONE · 55
PDF
A Review of Gene Expression Profiling of Human Embryonic Stem Cell Lines and their Differentiated Progeny
2009 · Bhaskar Bhattacharya, Sachin Puri, et al. · Current Stem Cell Research & Therapy · 47
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
2022 · Sachin Puri, Katja Stefan, et al. · Journal of Medicinal Chemistry · 44
PDF
Sustained Complete Response to CTLA-4 Blockade in a Patient with Metastatic, Castration-Resistant Prostate Cancer
2014 · Julie N. Graff, Sachin Puri, et al. · Cancer Immunology Research · 42
PDF
Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors
2009 · Kunzang Chosdol, Anjan Misra, et al. · BMC Cancer · 40
PDF
A comprehensive review on the indazole based derivatives as targeted anticancer agents
2023 · Sachin Puri, Siddhi Sawant, et al. · Journal of Molecular Structure · 38
Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study
2022 · Sachin Puri, Iqrar Ahmad, et al. · Toxicology in Vitro · 32
Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
2009 · Ulf Petrausch, Christian Poehlein, et al. · Current Molecular Medicine · 32
Surface decorated quantum dots: Synthesis, properties and role in herbal therapy
2023 · Mirza Shahed Baig, Ravikiran Maheshrao Suryawanshi, et al. · Frontiers in Cell and Developmental Biology · 24
PDF
Unraveling Berberine's Molecular Mechanisms in Neuroprotection Against Neurodegeneration
2025 · Md. Zamshed Alam Begh, Md Al Amin, et al. · Chemistry & Biodiversity · 23
Synthesis and evaluation of tryptanthrin derivatives as promising anticancer agents: In vitro, in silico, and SAR insights
2024 · Bhagyashri Rathod, Sachin Puri, et al. · Journal of Molecular Structure · 19
Recent Advancements and Developments in the Biological Importance of 1,3,5‐Triazines
2024 · Bhagyashri Rathod, Swati Pawar, et al. · ChemistrySelect · 19
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
2017 · Rachel E. Sanborn, Helen J. Ross, et al. · Journal for ImmunoTherapy of Cancer · 19
PDF
Expression and structure of interleukin 4 receptors in primary meningeal tumors
2005 · Sachin Puri, Bharat H. Joshi, et al. · Cancer · 17
Facile synthesis of new N1-alkylated 1H-indazole-3-carboxamide derivatives as potential anticancer agents: In vitro, ADMET prediction, and SAR studies
2022 · Sachin Puri, Kapil Juvale · Journal of Molecular Structure · 14
A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy
2009 · Sachin Puri, Surbhi Puri, et al. · Current Molecular Medicine · 13
Diversified Synthetic Strategies of Quinoline and Its Derivatives: A Review
2025 · Kapil Kumar, Sachin Puri, et al. · Journal of Heterocyclic Chemistry · 11
Functional and structural polypharmacology of indazole-based privileged ligands to tackle the undruggability of membrane transporters
2025 · Katja Stefan, Sachin Puri, et al. · European Journal of Medicinal Chemistry · 7
T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts).
2017 · Bernard A. Fox, Brian C. Boulmay, et al. · Journal of Clinical Oncology · 7
Facile synthesis of 6-substituted tryptanthrin derivatives as promising anticancer agents: In vitro, ADMET prediction, and molecular docking studies
2025 · Bhagyashri Rathod, Sachin Puri, et al. · Journal of Molecular Structure · 6
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
2018 · Rieneke van de Ven, Traci L. Hilton, et al. · OncoImmunology · 6
Chemical noise and signal fidelity in stimuli-responsive drug delivery systems
2026 · Bhagyashri Rathod, Sachin Puri · International Journal of Pharmaceutics · 5
Works count: 56
Citation count: 929
H-index: 17
I10-index: 20
Year
Topic
Type